Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,9 USD | +20,61% | -2,47% | +558,33% |
Vakgebied
Aantal werknemers: 8
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Natural Bioactive Ingredients
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 01-01-21 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Harlan L. Miller
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01-05-13 | |
William P. Pfund
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 17-09-14 | |
Director/Board Member | 58 | 28-08-13 | |
John Payne
CEO | Chief Executive Officer | 76 | 19-07-13 |
Alison Cornell
BRD | Director/Board Member | 62 | 08-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 802 988 | 1 675 876 ( 59,79 %) | 0 | 59,79 % |
Bedrijfsgegevens
Zivo Bioscience, Inc.
21 East Long Lake Road Suite 100
48304, Bloomfield Hills
+(248) 452 9866
http://www.zivobioscience.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+558,33% | 22,14 mln. | |
+13,21% | 8,15 mld. | |
-0,47% | 7,27 mld. | |
+12,30% | 6,65 mld. | |
-6,99% | 3,72 mld. | |
-6,60% | 3,67 mld. | |
-4,78% | 1,31 mld. | |
+12,61% | 972 mln. | |
-11,87% | 876 mln. | |
-38,50% | 866 mln. |
- Beurs
- Aandelen
- Koers ZIVO
- Onderneming ZIVO Bioscience, Inc.